MLTC-M Community of Practice in Clinical Context and Pathways (Clinical Community of Practice)
MLTC-M Community of Practice in Clinical Context and Pathways (Clinical Community of Practice)
批准号:
MR/X004562/1
负责人:
Jane Masoli
金额:
$5.82万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
People tend to accumulate health problems and diagnoses. When several long-term health problems or diagnoses co-exist it is called multimorbidity. Our research is funded by the Strategic Priorities Fund as multimorbidity is now recognised as a huge problem in the UK and across the world. Traditionally, clinical research has focussed on one health condition, and often people with several diagnoses, or multimorbidity, have been excluded from research studies. We are asking for funding to work together between the research groups on multimorbidity. We aim to create a Community of Practice for clinicians (doctors, nurses, pharmacists, physiotherapists or from any clinical background) working on multimorbidity research. This clinical "Community of Practice" (CoP) will provide an opportunity for clinicians researching multimorbidity in separate research groups to meet each other, learn, share ideas and come up with new ideas together to form future research.The clinical CoP will be focussed around an online platform, where we can interact with each other and form groups with specific focuses. For example, some health problems can be diagnosed without question - such as heart attack or stroke - while others are more complicated to define, such as mental health conditions, pain or incontinence. Even more complicated is linking different health problems into clusters. These smaller groups might focus on these complex areas. We will run a face-to-face launch event and work together to see what the priorities should be - we want to make sure that we work effectively to overcome the biggest challenges. After that, we will communicate with our members on the online platform (which we hope to develop with other clinical researchers in multimorbidity, via the National Institute of Health Research (NIHR)), on social media via a specific hashtag, and by a monthly newsletter. Our core group of investigators will meet every 3 months. 6 virtual workshops will be run on key topics. We will make sure that we talk to other funded CoPs to see if we can work together on specific topics to combine our clinical skills with their skills: for example with the proposed Statistical Methods CoP and Patient and Public Involvement and Engagement. We will conduct a survey via our networks to try to understand what clinicians think are the key priorities for multimorbidity research, which we will write up for publication and which is likely to lead on to other work in this area.The CoP will support the communication of this multimorbidity research to clinicians, and help to increase multimorbidity research and research delivery capacity. We will host symposiums, and already have agreement in principle from key partners in primary care and geriatric medicine to feature CoP research in their conferences. We will also host an event towards the end of the CoP funding as a clinical showcase to a wider clinical audience and other interested people. A further key way in which the clinical CoP can support multimorbidity work is to consider the next steps in this research and how we can move towards patient benefit. We anticipate that this will be the focus of a working group, a virtual workshop and a writing group to work together on future funding proposals. We have the support of the NIHR Clinical Research Network leads in Primary Care and Ageing, who have told us that they fully support this clinical CoP as it will facilitate early communication about planning future research.Overall, this clinical CoP aims to accelerate progress in multimorbidity research, while ensuring that it is clinically relevant, train and enthuse clinicians to work and lead multimorbidity research and plan pathways to patient impact. By working with key partners, developing a sustainable online platform for the wider multimorbidity research community and development of future funding proposals this clinical CoP legacy will outlast the funding.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Genomics and multimorbidity.
基因组学和多发病。
DOI:
10.1093/ageing/afac285
发表时间:
2022
期刊:
Age and ageing
影响因子:
6.7
作者:
[Masoli JAH]
通讯作者:
Masoli JAH
海外基金